Press Releases

Conagen Expands Natural Preservation by Fermentation

Bedford, Mass., Aug. 24, 2021 (GLOBE NEWSWIRE) — As the “clean label” trend thrives in many consumer product categories, Massachusetts-based biotech Conagen announced the launch of a natural preservative, p-Coumaric Acid (PCA). Conagen’s PCA is made by fermentation and expands

Read More

Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer

– Toripalimab plus chemotherapy met primary endpoint with significant improvement in PFS compared to chemotherapy alone – – Data support the use of toripalimab with chemotherapy as first-line therapy for patients with NSCLC – – Study to be presented September

Read More

Conagen Expands Natural Preservation by Fermentation

Bedford, Mass., Aug. 24, 2021 (GLOBE NEWSWIRE) — As the “clean label” trend thrives in many consumer product categories, Massachusetts-based biotech Conagen announced the launch of a natural preservative, p-Coumaric Acid (PCA). Conagen’s PCA is made by fermentation and expands

Read More

Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer

– Toripalimab plus chemotherapy met primary endpoint with significant improvement in PFS compared to chemotherapy alone – – Data support the use of toripalimab with chemotherapy as first-line therapy for patients with NSCLC – – Study to be presented September

Read More